You have 9 free searches left this month | for more free features.

newly diagnosed acute myeloid leukemia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Wuhan (Basic

Recruiting
  • UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
  • Basic chemotherapy + UCB transplantation
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Oct 9, 2022

Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

Recruiting
  • Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • "3+7"
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Sep 29, 2023

Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028 Dose Escalation)

Recruiting
  • Newly Diagnosed Acute Myeloid Leukemia (AML)
  • SKLB1028 Dose Escalation
  • Chengdu, China
    West China Hospital of Sichuan University
Jun 30, 2022

Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)

Recruiting
  • Acute Myeloid Leukemia
  • Azacitidine Combined With Venetoclax and ATRA group
  • Suzhou, China
    the First Affiliated Hospital of Soochow University
Dec 8, 2022

Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • AML Stage, Adult
  • Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
  • Xiamen, Fujian, China
    Bing Xu
Oct 29, 2022

Venetoclax Plasma Concentration and Remission in Acute Myeloid

Not yet recruiting
  • Adult Acute Myeloid Leukemia
  • Blood sampling for venetoclax drug dosage (venous puncture)
  • (no location specified)
Sep 13, 2023

Acute Myeloid Leukemia (AML) Trial in Tianjin (Quizartinib)

Completed
  • Acute Myeloid Leukemia (AML)
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
Jul 27, 2022

Acute Myeloid Leukemia Trial in Chicago (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    Northwestern University
Feb 16, 2023

Single-cell Dynamic Profiling in Newly Diagnosed Acute Myeloid

Not yet recruiting
  • Acute Myeloid Leukemia
  • Biobanking blood and bone marrow specimens
  • (no location specified)
Mar 21, 2022

Acute Myeloid Leukemia Trial in Tampa (Vyxeos, Gemtuzumab Ozogamicin)

Recruiting
  • Acute Myeloid Leukemia
  • Tampa, Florida
    Moffitt Cancer Center
Sep 23, 2022

Leukemia, Myeloid, Acute Trial in Japan (Cusatuzumab, Azacitidine)

Completed
  • Leukemia, Myeloid, Acute
  • Fukushima, Japan
  • +4 more
Aug 8, 2022

Acute Myeloid Leukemia, MDS Trial in Ulm (drug, combination product, other)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Berlin, Germany
  • +9 more
Jan 13, 2023

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Recruiting
  • Acute Bilineal Leukemia
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 24, 2023

Acute Myeloid Leukemia Trial in Baltimore, New York, Chapel Hill (Alvocidib, Cytarabine, Daunorubicin)

Completed
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
  • +2 more
Apr 4, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Biospecimen Collection
  • +3 more
  • Baltimore, Maryland
  • +2 more
Jan 19, 2023

AML, Acute Myeloid Leukemia Trial in Charlottesville (Cardioprotection)

Recruiting
  • AML
  • Acute Myeloid Leukemia
  • Charlottesville, Virginia
    University of Virginia
Jul 2, 2022

Acute Myeloid Leukemia, MDS Trial in Bronx (Venetoclax Oral Tablet, Daunorubicin, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Venetoclax Oral Tablet
  • +2 more
  • Bronx, New York
    Montefiore Einstein Cancer Center
Jul 14, 2022

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 2, 2023

Acute Myeloid Leukemia Trial in Germany (Venetoclax plus Azacitidine, standard of care chemo plus gemtuzumab ozogamicin)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Venetoclax plus Azacitidine
  • standard of care chemotherapy plus gemtuzumab ozogamicin
  • Essen, NRW, Germany
  • +17 more
Jun 6, 2023

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Decitabine and

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 1, 2022

Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Suzhou, Jiangsu, China
    Qiu Huiying
Mar 28, 2023

Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    Sep 22, 2023

    AML, Adult Trial in Chicago, Charlottesville (BST-236, venetoclax)

    Recruiting
    • AML, Adult
    • Chicago, Illinois
    • +1 more
    Aug 17, 2022

    Acute Myeloid Leukemia Trial in Kunming (Venetoclax in combination with azacitidine and CAG)

    Recruiting
    • Acute Myeloid Leukemia
    • Venetoclax in combination with azacitidine and CAG
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Dec 20, 2022